Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan

Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan

BACKGROUND: Sacubitril/valsartan (S/V) improve left ventricular ejection fraction (LVEF) in heart failure patients, but the magnitude of improvement may depend on baseline values. METHODS: We analyzed whether baseline LVEF can predict its improvement in patients with LVEF ≤ 45% receiving S/V. Patien...

Full description

Saved in:
Bibliographic Details
Main Authors: José-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, Francisco de Asís Díaz Cortegana, Loreto Bravo Calero, Cristina Aguilera Agudo, José María Romero-Otero, José Tuñón Fernández
Format: Article
Language:English
Published: Via Medica 2025-06-01
Series:Cardiology Journal
Subjects:
left ventricular ejection fraction
sacubitril/valsartan
Online Access:https://journals.viamedica.pl/cardiology_journal/article/view/104310
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.viamedica.pl/cardiology_journal/article/view/104310

Similar Items